In 2024, the S&P 500 is poised to rise 23.8%, significantly outperforming past years. However, gains are uneven, with communication services up over 40% while materials fell nearly 2%. Major underperformers include Walgreens Boots Alliance, which has dropped over 64% amid ongoing struggles in its retail pharmacy sector, and Intel, down over 60% due to competitive losses and leadership changes. Moderna also faces a decline of more than 60%, as interest shifts from Covid vaccines to weight-loss drugs. Analysts generally maintain hold ratings but see potential for rebounds across these stocks.
